Your browser doesn't support javascript.
loading
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics.
Haselbeck, Andrea Haekyung; Tadesse, Birkneh Tilahun; Park, Juyeon; Gibani, Malick M; Espinoza, Ligia María Cruz; Abreu, Ariane; Van Rensburg, Craig; Owusu-Ansah, Michael; Twuamsi-Ankrah, Sampson; Owusu, Michael; Aguna, Isaac; Picot, Valentina; Jeon, Hyonjin; Higginson, Ellen; Park, Sunju; Mojares, Zenaida R; Im, Justin; Carey, Megan E; Khanam, Farhana; Tonks, Susan; Dougan, Gordon; Kim, Deokryun; Sugimoto, Jonathan; Mogasale, Vittal; Neuzil, Kathleen M; Qadri, Firdausi; Adu-Sarkodie, Yaw; Owusu-Dabo, Ellis; Clemens, John; Marks, Florian.
Afiliação
  • Haselbeck AH; International Vaccine Institute, Seoul 08826, Korea.
  • Tadesse BT; International Vaccine Institute, Seoul 08826, Korea.
  • Park J; International Vaccine Institute, Seoul 08826, Korea.
  • Gibani MM; Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0SL, UK.
  • Espinoza LMC; Department of Infectious Disease, Imperial College of Medicine, London SW7 2AZ, UK.
  • Abreu A; International Vaccine Institute, Seoul 08826, Korea.
  • Van Rensburg C; International Vaccine Institute, Seoul 08826, Korea.
  • Owusu-Ansah M; International Vaccine Institute, Seoul 08826, Korea.
  • Twuamsi-Ankrah S; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi 00000, Ghana.
  • Owusu M; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi 00000, Ghana.
  • Aguna I; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi 00000, Ghana.
  • Picot V; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi 00000, Ghana.
  • Jeon H; Fondation Mérieux, 69002 Lyon, France.
  • Higginson E; International Vaccine Institute, Seoul 08826, Korea.
  • Park S; Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0SL, UK.
  • Mojares ZR; Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0SL, UK.
  • Im J; International Vaccine Institute, Seoul 08826, Korea.
  • Carey ME; International Vaccine Institute, Seoul 08826, Korea.
  • Khanam F; International Vaccine Institute, Seoul 08826, Korea.
  • Tonks S; Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0SL, UK.
  • Dougan G; International Centre for Diarrhoeal Disease Research, Dhaka 1212, Bangladesh.
  • Kim D; Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0SL, UK.
  • Sugimoto J; Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0SL, UK.
  • Mogasale V; International Vaccine Institute, Seoul 08826, Korea.
  • Neuzil KM; Seattle Epidemiologic Research and Information Center, Cooperative Studies Program, Office of Research and Development, United States Department of Veterans Affairs, Seattle, WA 98174, USA.
  • Qadri F; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Adu-Sarkodie Y; Department of Epidemiology, University of Washington, Seattle, WA 98195, USA.
  • Owusu-Dabo E; International Vaccine Institute, Seoul 08826, Korea.
  • Clemens J; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Marks F; International Centre for Diarrhoeal Disease Research, Dhaka 1212, Bangladesh.
Vaccines (Basel) ; 9(3)2021 Mar 19.
Article em En | MEDLINE | ID: mdl-33808924
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article